1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsAdvancing Genomic Medicine Research through Small Businesses is sponsored by National Human Genome Research Institute (NHGRI). Seeks Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) grant applications in the field of genomic medicine.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
NHGRI Small Business Program NHGRI Small Business Program The National Human Genome Research Institute (NHGRI) Small Business Program awards Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) grants for projects that fit our mission and vision . NHGRI strives to improve the health of all humans through advances in genomics research.
As a leading authority in the field of genomics, our mission is to accelerate scientific and medical breakthroughs that improve human health. We do this by driving cutting-edge research, developing new technologies, and studying the impact of genomics on society.
NIH SBIR and STTR Programs For applications that align with a range of specific topics in genomics (see page 29), NHGRI application caps (total costs not including technical and business assistance ) allow requests of up to $400,000 for Phase I and up to $2,150,000 for Phase II.
The NHGRI Small Business Program is interested in a wide breadth of work in genomics, including: Genomic Technology Development Computational Genomics and Data Science Learn more about the ins and outs of the NHGRI Small Business Program from the following presentation featured at the 102nd Meeting of the National Advisory Council for Human Genome Research: If you think your research aligns with our institute, you are strongly recommended to contact program staff in the developmental stages of your application to ensure your proposed research aligns with NHGRI’s mission, vision, and interests.
NIH SBIR and STTR Programs Many government agencies, including the National Institutes of Health (NIH), fund small businesses through congressionally mandated set-aside funds. Each Institute and Center (IC) within the NIH has its own small business program and funds SBIR and STTR grants to encourage research and the development of innovative technologies that improve health and have a strong potential for commercialization.
NIH has a central Small Business Education and Entrepreneurial Development (SEED) office that develops and implements strategies and policies related to the NIH-wide small business program and provides support for the small business community. The SEED team manages the NIH SBIR-STTR Listserv, which provides relevant information about opportunities and updates for those interested in NIH small business opportunities.
SBIR and STTR programs have similar goals, but STTR projects occur at an earlier stage in technology transfer and are more closely connected to the research institution, while SBIRs occur at a later stage in technology transfer and are more closely connected to the small business.
Small Business Innovation Research (SBIR) Small Business Technology Transfer (STTR) Project leadership The principal investigator must be primarily employed by the small business. The principal investigator can be employed by the small business or the academic institution. Non-profit research partner A partnership with a non-profit research partner is not required.
A formal agreement with a non-profit research institution is required. Learn more about the differences between SBIR and STTR grants . These programs are divided into 3 phases: There are also opportunities for: Fast Track Applications where the Phase I and Phase II are submitted together and reviewed in one application.
Direct to Phase II Applications for proposed Phase II work where proof of principle results were funded by means other than SBIR or STTR funding. Learn more about the different types of applications (Phase I, Phase II, Fast-track, and Direct to Phase II).
SBIR and STTR programs have similar goals, but STTR projects occur at an earlier stage in technology transfer and are more closely connected to the research institution, while SBIRs occur at a later stage in technology transfer and are more closely connected to the small business.
Small Business Innovation Research (SBIR) Small Business Technology Transfer (STTR) Project leadership The principal investigator must be primarily employed by the small business. The principal investigator can be employed by the small business or the academic institution. Non-profit research partner A partnership with a non-profit research partner is not required.
A formal agreement with a non-profit research institution is required. Learn more about the differences between SBIR and STTR grants . These programs are divided into 3 phases: There are also opportunities for: Fast Track Applications where the Phase I and Phase II are submitted together and reviewed in one application.
Direct to Phase II Applications for proposed Phase II work where proof of principle results were funded by means other than SBIR or STTR funding. Learn more about the different types of applications (Phase I, Phase II, Fast-track, and Direct to Phase II). An Omnibus Solicitation extends across multiple agencies including the NIH, Centers for Disease Control and Prevention (CDC), and the Food and Drug Administration (FDA).
Applicants can submit applications for Omnibus opportunities at standard dates . NHGRI is always interested in responses to the Omnibus Solicitation, also known as the Parent Funding Opportunity Announcement, that relate to our mission .
Targeted NHGRI Solicitations PAR-24-131 : Small Business Transition Grant for New Entrepreneurs (R43/R44 Clinical Trial Not Allowed) PAR-24-132 : Small Business Transition Grant for New Entrepreneurs (R43/R44 Clinical Trial Required) PAR-24-133 : Small Business Transition Grant for New Entrepreneurs (R41/R42 Clinical Trial Not Allowed) PAR-24-134 : Small Business Transition Grant for New Entrepreneurs (R41/R42 Clinical Trial Required) PAR-23-219 : SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, Clinical Trial Not Allowed) PAR-24-262 : STTR Solutions to Enable Population Genomic Screening (R41/R42 Clinical Trial Optional) PAR-24-263 : SBIR Solutions to Enable Population Genomic Screening (R43/R44 Clinical Trial Optional) Notices of Special Interest (NOSIs) NOT-HG-24-002 : Notice of Special Interest: Advancing Genomic Medicine Research through Small Businesses NOT-HG-22-007 : Methods Development for Genomic Studies of Genetic Variation, Function, and Disease NOT-HG-22-011 : Notice of Special Interest: Development and Implementation of Clinical Informatics Tools to Enhance Patients Use of Genomic Information NOT-HG-21-038 : Notice of Special Interest (NOSI): Genomics Education Interactive Digital Media Resources (SBIR/STTR) NOT-HG-24-036 : Notice of Special Interest (NOSI): Advancing Genomic Technology Development for Research and Clinical Application NOT-OD-23-179 : Notice of Special Interest: Encouraging Small Businesses to Partner with Resource-Limited Institutions (RLIs) on Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Program Applications NOT-HG-24-016 : Notice of Special Interest: Advancing Genomic Medicine Research through Small Businesses NOT-HG-24-040 : Notice of Special Interest: Small Business Solutions to Assist Genomics-Enabled Learning Health Systems (gLHS) NOT-HG-24-041 : Notice of Special Interest: Small Business Solutions to Enable Regional Genomic Medicine eConsult Services NOT-OD-24-077 : Notice of Special Interest: Technical and Business Assistance (TABA) Funding May be Added to an SBIR/STTR Award by Administrative Supplement NIH SBIR and STTR Programs Frequently Asked Questions Small Business Success Stories NIH Company Showcase Program Sample SBIR/STTR Applications From National Institute of Allergy and Infection Disease (NIAID) From National Cancer Institute (NCI) From National Institute on Aging (NIA) Eligibility and Application Process Resources Small Business Eligibility Criteria Understanding the Review Process Tips for a Successful Phase II Application Research Involving Human Subjects Institutional Review Board (IRB) Approval Human Subjects Education Certifications Research Involving Vertebrate Animals Institutional Animal Care and Use Committee Modular Learning about Biotech operations, functions, and skills (DRIVEN Accelerator Hub) SBIR For Newbies (XLERATOR hub) STTR Regional Technology Transfer Accelerator Hubs for IDeA States Send questions to nhgri_smallbusiness@nih.
gov . NHGRI Small Business Program Renee Rider, M. S.
, J. D. , LCGC NHGRI Small Business Program Stephanie A.
Morris, Ph. D. Division of Genome Sciences Division of Genome Sciences Division of Genome Sciences Scientific Program Analyst Division of Genome Sciences Last updated: March 11, 2025
According to the current listing, eligibility includes: Small businesses. Confirm the full requirements in the official notice before applying.
The current listing shows up to $400,000 for Phase I; up to $2,150,000 for Phase II. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Advancing Genomic Medicine Research through Small Businesses is funded by National Human Genome Research Institute (NHGRI). Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.
Wellcome Discovery Awards provide long-term flexible funding for established researchers and teams pursuing bold, creative research that can deliver significant shifts in understanding of human life, health, and wellbeing. AI and computational approaches to biomedical challenges are explicitly welcome, including machine learning for drug discovery, AI-driven clinical diagnostics, computational genomics, and data science for health equity. The world's second largest private funder of medical research (endowment approximately £14.5 billion), Wellcome supports interdisciplinary teams tackling fundamental health questions using novel methodologies. Discovery Awards are discipline-agnostic and value transformative potential over incremental advances, making them ideal for ambitious AI-health intersection research.
Advanced Digital Skills for AI Uptake in Health is sponsored by European Commission — Digital Europe Programme. Expected Outcome: Deliverables: Initiatives implemented for the target audience to collect knowledge on learning needs in the area of AI uptake in health. Training programmes in the area of advanced digital skills for AI uptake in health, designed jointly by higher education institutions, VET providers, research organisations, businesses and other stakeholders in digital health, in collaboration with the network of AI-powered advanced screening centres. Training catalogue with detailed course planning and timetable, regularly updated. Final analysis of the completed training and the achievement level reached in improved skills. A landing page integrated into the Digital Skills and Jobs Platform, showcasing existing and forthcoming education and training initiatives and promoting training offers to the relevant audience. Objective: The academic offer in the area of advanced digital technologies in the EU is still lagging behind other regions of the world, especially when compared to the United Kingdom or the United States [1] even though the number of both bachelor’s and master’s programmes in the EU has increased through the years. Furthermore, apart from delivering excellent programmes in specific digital technologies, there is also a growing demand for interdisciplinary programmes to equip sector specialists with the digital skills to deploy and use advanced digital technologies. The actions under this topic aim at tackling the lack of academic training offer in advanced digital skills in key digital areas, while triggering a new way of delivering education programmes and training, building partnerships between education and training providers, businesses and research across the EU, and supporting the digital skills necessary for the deployment of digital technologies in strategic sectors. 1 This represents an increase of 8% in the number of bachelor programmes and an increase of 14% in the number of master programmes in the area of advanced digital skills. The dataset by the Joint Research Centre on the ‘Academic offer of advanced digital technologies 2022-2023’ is available here: JRC Data Catalogue - Dataset - European Commission Scope: This topic aims to expand the offer of education and training in Artificial Intelligence in health jointly designed between higher education and training institutions, research organisations and industry. The content must reflect the latest policy developments, notably the Apply AI Strategy [1] and the European Health Data Space [2] . It should cover developments in and application of AI and related digital health technologies. The target audience is healthcare professionals, as well as computer and data scientists, programmers, and software developers working in the healthcare sector. Trainings must reflect the learning needs of the target audience and will vary in depth and technical complexity to accommodate different levels of expertise and learning preferences. To this end, the proposed project(s) should design and deliver the trainings in cooperation with the Apply AI Strategy flagship “European network of AI-powered advanced screening centres” [3]. The training courses should be made available to members of the “European network of AI-powered advanced screening centres” at least quarterly. The training sessions and material should be available in English and other EU languages, considering the needs of the target audience that need to be established. The training catalogue and content should be adapted regularly, according to target audience feedback. Whenever applicable, the projects should foster the use of the HealthData@EU infrastructure and other European health data infrastructures (Genomic Data Infrastructure, Cancer Image Europe, the European Virtual Human Twins advanced platform, ICU data space), explore synergies and build on relevant education and training activities developed and provided in the context of those initiatives, as well as in the relevant projects funded by E Programme areas: DIGITAL-1 Keywords: Artificial intelligence, Artificial intelligence, intelligent systems, multi agent systems, Computer sciences - Operating systems (software development only), Continuing professional training, Curriculum design and development, Design of innovative master related to European Innovation potential, Digital Services and Platforms, Education, Education and Training, Health and Ecosystem Services, Health data, Health sciences, IT skills and competence, Identification of skills needs, Inclusive Education, Integration and upscaling of digital technologies and media in education, Interoperability, Learning outcomes, Master's or equivalent, New employement profiles and identification of skills, Personal development, Qualification, Teaching materials, Technological innovation, Training, Advanced Digital Skills, Cross-Sectoral Collaboration, Digital Health Education, European Health Data Space and infrastructure, European Health Initiatives, Health Workforce Development, Health care professionals, Health care students, High level expertise for healthcare, STEP-Digital/deep tech
On August 26, 2026, NSF named the STC class of 2026: TEMPEST at Michigan State, GENIE at Northwestern, and a human-robot co-adaptation center at UT Austin. $90 million total, $6 million a year each. The 2023 class was four centers and $120 million. The award size is intact; the shelf space shrank 25 percent — and that is the number that should reshape how you plan a center proposal.
Read articleWhile headlines chase AI and defense money, USDA's National Institute of Food and Agriculture runs a tight summer competitive cycle — Equipment Grants (June 25), Agricultural Genome to Phenome (June 29), New Beginning for Tribal Students (July 2), and Crop Protection and Pest Management (July 6). Here is how the four programs fit together, who is eligible, and why the land-grant system has a structural edge.
Read articleThe STOMP program funds measurement tools and removal therapies for microplastics in human tissue. Proposals due June 22. Eligibility, phases, and strategy.
Read article